THOC6: A Protein with Potential as A Drug Target Or Biomarker

Target Name: THOC6

NCBI ID: G79228

THOC6

THOC6: A Protein with Potential as A Drug Target Or Biomarker

THOC6 (fSAP35) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the SAP family of proteins, which are involved in the regulation of cell signaling pathways. The primary function of THOC6 is to interact with and regulate the activity of the protein p21 (also known as CDK4), which is a key regulator of cell growth and division.

THOC6 has been shown to play a role in the regulation of various cellular processes, including cell growth, apoptosis (programmed cell death), and inflammation. It has also been shown to be involved in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Due to its involvement in these processes, THOC6 has been identified as a potential drug target or biomarker. Researchers are currently exploring the use of THOC6 as a therapeutic approach for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the main advantages of THOC6 as a drug target is its expression in a variety of tissues, which makes it a potential therapy that can be administered to a wide range of patients. Additionally, the fact that THOC6 is involved in the regulation of cell signaling pathways makes it a potential therapy that can be used to treat a variety of diseases.

In addition to its potential as a drug target, THOC6 has also been shown to be a potential biomarker for a variety of diseases. The fact that THOC6 is expressed in various tissues makes it a potential indicator of disease, and its involvement in the regulation of cellular processes makes it a potential indicator of the severity of disease.

Research has also shown that THOC6 is involved in the development and progression of various diseases, including cancer. THOC6 has been shown to be involved in the regulation of the growth and division of cancer cells, which makes it a potential target for cancer therapies.

Additionally, THOC6 has also been shown to be involved in the regulation of neurodegenerative diseases. THOC6 has been shown to be involved in the regulation of the growth and differentiation of neural cells, which makes it a potential target for therapies aimed at treating neurodegenerative diseases.

In addition to its potential as a drug target and biomarker, THOC6 has also been shown to be involved in the regulation of various physiological processes in the body. THOC6 has been shown to be involved in the regulation of cell migration, which is important for the development and progression of many diseases, including cancer.

Overall, THOC6 is a protein that has the potential to be a drug target or biomarker for a variety of diseases. Further research is needed to fully understand its role in these processes and to develop effective therapies based on its properties.

Protein Name: THO Complex Subunit 6

Functions: Acts as component of the THO subcomplex of the TREX complex which is thought to couple mRNA transcription, processing and nuclear export, and which specifically associates with spliced mRNA and not with unspliced pre-mRNA. TREX is recruited to spliced mRNAs by a transcription-independent mechanism, binds to mRNA upstream of the exon-junction complex (EJC) and is recruited in a splicing- and cap-dependent manner to a region near the 5' end of the mRNA where it functions in mRNA export to the cytoplasm via the TAP/NFX1 pathway. The TREX complex is essential for the export of Kaposi's sarcoma-associated herpesvirus (KSHV) intronless mRNAs and infectious virus production. Plays a role in apoptosis negative control involved in brain development

The "THOC6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about THOC6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets